Biological Age: Five Approaches to Measuring How You Really Age

Biological age estimates the actual functional state of the body based on molecular, metabolic, and physiological markers. Unlike chronological age, which merely counts years, it quantifies the speed and extent of decline across biological systems. Two individuals aged 55 can diverge by more than 15 years in biological age depending on their inflammatory, metabolic, and epigenetic profile (PubMed).

This divergence is not anecdotal. The Dunedin cohort study, following a thousand individuals since their birth in 1972-73, demonstrated that biological aging differences are already measurable at age 38. Some participants aged at a rate of 0.4 biological years per calendar year. Others at 2.4 biological years per calendar year. Six times faster. And this acceleration predicted cognitive decline, physical frailty, and older perceived appearance as rated by independent assessors (PubMed).

The question is no longer whether biological aging differs from calendar aging. It is how to measure it. Five approaches exist today, each with its strengths and limitations.

Epigenetic clocks: the academic gold standard

DNA methylation (the addition of small chemical groups to specific letters of the genetic code) changes predictably over a lifetime. In 2013, Steve Horvath showed that 353 of these sites are sufficient to estimate chronological age with a median error of 3.6 years (PubMed).

Since then, clocks have evolved. GrimAge, published in 2019, no longer measures age but mortality risk, by integrating epigenetic surrogates of plasma proteins associated with aging (PubMed). DunedinPACE, developed by Belsky's team in 2022, measures the pace of aging rather than a static age: a score of 1.2 means the individual is aging 20% faster than average (PubMed).

Epigenetic clocks remain the most validated method in research. Their limitation for the general public is threefold: high cost (€200 to €500 per test), need for a specialized laboratory, and variable reproducibility across commercial providers. For a deeper exploration of DNA methylation and clock mechanisms, we have devoted a dedicated article to this topic.

Blood biomarkers: the most accessible proxy

A standard blood draw contains a considerable amount of information about the aging trajectory. Several biomarkers, available in any clinical laboratory, are individually correlated with all-cause mortality and accelerated aging.

hs-CRP (high-sensitivity C-reactive protein) measures low-grade systemic inflammation, the process most consistently associated with aging across all organ systems. A chronically elevated hs-CRP (above 3 mg/L) is associated with increased cardiovascular risk, faster cognitive decline, and higher mortality (PubMed).

HbA1c (glycated hemoglobin) reflects glycemic control over the past 2 to 3 months. Glucose dysregulation is one of the central mechanisms of accelerated aging. Each 1% increase in HbA1c above the normal threshold is associated with a significant increase in cardiovascular risk, even in non-diabetics (PubMed).

Homocysteine is the byproduct of the one-carbon cycle that supplies the methyl groups required for DNA methylation. Its elevation signals a cycle under strain. NHANES data show that a doubling of plasma homocysteine is associated with a 1.93-year acceleration on GrimAge2 (PubMed).

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) evaluates insulin resistance from fasting glucose and insulin levels. Insulin resistance is a metabolic crossroads of aging, linked to inflammation, ectopic lipid storage, and mitochondrial dysfunction (PubMed).

Ferritin reflects the body's iron stores. Iron is a potent pro-oxidant: in excess, it catalyzes free radical formation through the Fenton reaction. Elevated ferritin levels are associated with accelerated aging and increased cardiometabolic risk in cohort studies (PubMed).

None of these markers alone constitutes a "biological age." It is their combined reading, tracked over time, that reveals a trajectory. Several composite algorithms attempt to integrate these data into a single score. The best known is the KDM Biological Age, developed by Morgan Levine, which combines ten clinical biomarkers (albumin, creatinine, glucose, CRP, lymphocytes, mean cell volume, alkaline phosphatase, white blood cells, systolic blood pressure, blood urea nitrogen) to estimate a biological age correlated with mortality (PubMed).

Plasma proteomics: aging in waves

Proteomics (the large-scale analysis of proteins circulating in the blood) opens an unprecedented window into systemic aging. Instead of measuring a few biomarkers, it measures thousands simultaneously.

The Lehallier et al. study (2019), covering 2,925 individuals aged 18 to 95, revealed an unexpected finding: proteomic aging does not progress linearly. It advances in waves, with major inflections around ages 34, 60, and 78 (PubMed).

At 34, the first wave marks the transition between the end of biological maturation and the onset of decline. At 60, a massive shift in the plasma proteome suggests a profound reorganization of biological systems. At 78, the third wave coincides with entry into a zone of increased frailty.

These findings have two implications. The first is practical: aging is not a gradual process. There are windows of biological vulnerability. The second is methodological: a panel of a few blood proteins can predict chronological age with accuracy comparable to epigenetic clocks. The Ioannidis team showed that 373 proteins are sufficient to predict age within ±3 years (PubMed).

Proteomics is currently a research tool, not a routine test. But high-throughput platforms (SomaScan, Olink) make measuring hundreds of proteins technically feasible at decreasing cost. This is probably the method that will evolve the most in the next five years.

Functional measurements: the body as an instrument

Molecular approaches are not the only ones. Simple physiological measurements are associated with biological aging with robustness sometimes comparable to that of blood biomarkers.

Walking speed is the most studied predictor. A meta-analysis of 34,485 individuals over 65 showed that each 0.1 m/s increase in walking speed is associated with a 12% reduction in mortality risk (PubMed).

Grip strength (measured with a dynamometer) reflects functional muscle mass and neuromuscular function. Its decline is an early marker of sarcopenia and an independent predictor of all-cause mortality (PubMed).

VO2max (maximal oxygen consumption) measures the capacity of the cardiovascular system and mitochondria to use oxygen. Its decline with age (approximately 10% per decade after age 30) is one of the most predictive longevity markers. Individuals in the top VO2max quintile have a fivefold lower mortality risk than those in the bottom quintile (PubMed).

These measurements are free, reproducible, and accessible. They do not provide a biological age number, but they capture the functional dimension that molecular biomarkers, by definition, do not measure.

Limitations: why biological age is not yet a standardized clinical tool

The diversity of methods is also a weakness. There is no consensus on the definition of a single "biological age." Each clock, each algorithm, each biomarker panel measures a different facet of aging. Two tests performed on the same day on the same individual can yield divergent results.

Test-retest reproducibility is a documented problem. A 2023 study showed that some commercial epigenetic tests produced variations of 3 to 5 years between two samples taken weeks apart from the same individual (PubMed).

Cost remains a barrier. Epigenetic clocks cost €200 to €500 per test. Proteomic panels, €500 to €2,000. Only standard blood biomarkers are covered by healthcare systems.

Finally, the absence of prospective clinical validation limits the use of these tools in medical practice. Epigenetic clocks predict mortality in cohort studies, but no randomized trial has yet demonstrated that intervening based on biological age improves health outcomes compared to standard care.

Biological age as a longitudinal tracking metric

The value of biological age does not lie in a point-in-time number. It lies in its ability to trace a trajectory.

An individual who observes a decrease in hs-CRP, stabilization of HbA1c, and improvement in homocysteine over three consecutive panels obtains information that chronological age will never provide: confirmation that nutritional choices, physical activity, and sleep are actually bending biology in the right direction.

This is the logic of semi-annual monitoring. Not to obtain a verdict, but to measure a slope. Biological aging is not inevitable. It is a process in which 75 to 80% of the variance is attributable to modifiable factors: environment, nutrition, lifestyle (PubMed). The question is no longer whether aging can be slowed. It is whether we give ourselves the tools to verify it.

Frequently asked questions

What is the difference between biological age and chronological age?#[ + ]

Chronological age counts the years elapsed since birth. Biological age estimates the actual functional state of the body based on molecular, metabolic, or physiological markers. Two individuals aged 55 can show a biological age gap of 10 to 15 years depending on their inflammatory, metabolic, and epigenetic profile.

Can you measure biological age with a simple blood test?#[ + ]

Partially. Blood biomarkers such as hs-CRP (inflammation), HbA1c (glycemic control), homocysteine (one-carbon cycle), and HOMA-IR (insulin resistance) are correlated with accelerated aging in cohort studies. They do not provide a single biological age number, but a multidimensional risk profile that assesses the aging trajectory.

Are commercial biological age tests reliable?#[ + ]

Their reliability varies considerably. Validated epigenetic clocks (GrimAge, DunedinPACE) have a solid scientific foundation, but commercial tests differ in methodology, test-retest reproducibility, and CpG site panels used. A single result has little value. Repeated measurements over 6 to 12 months are needed to identify a reliable trend.

Which biomarkers are most predictive of accelerated aging?#[ + ]

Meta-analyses identify hs-CRP (chronic inflammation), HbA1c (glycemic dysregulation), homocysteine (one-carbon cycle stress), HOMA-IR (insulin resistance), and ferritin (iron overload) as the blood markers most strongly associated with all-cause mortality and functional decline. The Lehallier study identified proteomic signatures in waves at ages 34, 60, and 78.

How often should biological age be measured?#[ + ]

For meaningful longitudinal monitoring, an interval of 6 to 12 months is recommended. Measuring too frequently (monthly) mainly captures biological noise. Measuring too rarely (every 3-5 years) cannot detect trajectory inflections. Semi-annual monitoring offers the best balance between sensitivity to change and signal stability.

---

References

1. Belsky DW, Caspi A, Houts R, et al. Quantification of biological aging in young adults. Proc Natl Acad Sci USA. 2015;112(30):E4104-E4110 (PubMed).
2. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115 (PubMed).
3. Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303-327 (PubMed).
4. Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420 (PubMed).
5. Choi SW, Friso S. Modulation of DNA methylation by one-carbon metabolism: a milestone for healthy aging. Nutr Res Pract. 2023;17(4):597-615 (PubMed).
6. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-1565 (PubMed).
7. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800-811 (PubMed).
8. Lehallier B, Gate D, Schaum N, et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat Med. 2019;25(12):1843-1850 (PubMed).
9. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50-58 (PubMed).
10. Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273 (PubMed).
11. Mandsager K, Harb S, Cremer P, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605 (PubMed).
12. Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-591 (PubMed).
13. Herskind AM, McGue M, Holm NV, et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet. 1996;97(3):319-323 (PubMed).
14. Sugden K, Caspi A, Elliott ML, et al. Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia. Neurology. 2022;99(13):e1402-e1413 (PubMed).
15. Tian YE, Cropley V, Maier AB, et al. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med. 2023;29(5):1221-1231 (PubMed).
16. López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278 (PubMed).
17. Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008;100(14):996-1002 (PubMed).